LifeMD Inc reports results for the quarter ended December 31 - Earnings Summary

• LifeMD Inc LFMD.OQ reported a quarterly adjusted loss of 2 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of seven analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -8 cents to 1 cents per share.

• Revenue rose 43.2% to $64.25 million from a year ago; analysts expected $57.38 million.

• LifeMD Inc's reported EPS for the quarter was a loss of 2 cents​.

• The company reported a quarterly loss of $882.83 thousand.

• LifeMD Inc shares had fallen by 5.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 6.4% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for LifeMD Inc is $12.00

This summary was machine generated from LSEG data March 10 at 10:24 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)